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Abstract
Background: Tracheobronchial stenosis is a known complication of endobronchial tuberculosis. Despite antituberculous
and steroid therapy, the development of bronchial stenosis is usually irreversible and requires airway patency to
be restored by either bronchoscopic or surgical interventions. We report the use of balloon dilatation and topical
mitomycin-C to successful restore airway patency.
Case presentation: We present a 24-year old lady with previous pulmonary tuberculosis and laryngeal
tuberculosis in 2007 and 2013 respectively who presented with worsening dyspnoea and stridor. She had total
left lung collapse with stenosis of both the upper trachea and left main bronchus. She underwent successful
bronchoscopic balloon and manual rigid tube dilatation with topical mitomycin-C application over the stenotic
tracheal segment. A second bronchoscopic intervention was performed after 20 weeks for the left main bronchus
stenosis with serial balloon dilatation and topical mitomycin-C application. These interventions led to significant
clinical and radiographic improvements.
Conclusion: This case highlights that balloon dilatation and topical mitomycin-C application should be
considered in selected patients with tracheobronchial stenosis following endobronchial tuberculosis, avoiding
airway stenting and invasive surgical intervention.
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Background
Endobronchial tuberculosis (EBTB) is a consequence of
pulmonary TB (PTB) extending into the endobronchial
or endotracheal wall, and its incidence has been reported
to range from 6 to 50 % of cases [1–3]. EBTB can affect
any region of the tracheobronchial tree, with higher rates
of central EBTB (proximal to lobar bronchi) compared
to segmental bronchi [3]. The true incidence and
complications of EBTB are unknown as routine bron-
choscopy is not performed in all patients with PTB.
The clinical presentation of EBTB can be non-specific
with cough, dyspnoea and stridor; however patients may
also be asymptomatic. Generally, stridor occurs when
the proximal airway diameter in an adult diminishes to
approximately 6 mm [4]. Bronchial stenosis and stric-
tures are sequelae of EBTB and may develop in up to
95 % of cases despite adequate antituberculous therapy
[5, 6]. Eradication of the tubercle bacilli is the primary
goal of treatment for EBTB, similar to standard first line
treatment approaches Corticosteroids have improved
clinical outcomes when used as an adjunct therapy in
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children, however this has not been shown to prevent
bronchostenosis in adults and clinical concerns about its
immunosuppressive effects in this setting persist [7].
Despite antituberculous and steroid therapy, the devel-
opment of bronchial stenosis or strictures is usually irre-
versible and therefore requires airway patency to be
restored by either bronchoscopic or surgical interven-
tions [8]. There are various bronchoscopic techniques
including laser, balloon dilatation and stent insertion
[9–11]. We report a female patient who had two previ-
ous episodes of tuberculosis complicated by multi-level
fibrostenotic EBTB involving the left main bronchus
and the trachea. The left lung was successfully ex-
panded following serial endoscopic treatment with
subsequent use of mitomycin-C preventing the need for
an airway stent.
Case presentation
A 24-year-old female presented with a 3-month history
of worsening dyspnoea and stridor. She was unable to
climb one flight of stairs or walk more than 50 meters
on a flat surface, requiring domiciliary oxygen therapy.
She also had significant loss of appetite and loss of
weight. Her past medical history included acid-fast ba-
cilli (AFB) smear-positive PTB in 2007 and laryngeal TB
in 2013 for which she completed 6 months of standard
anti-tuberculous (anti-TB) regimen on both occasions.
Fig. 1 FV loop pre- and post-intervention. a FV loop showing flattening of inspiratory and expiratory limbs indicating fixed upper airway obstruction.
b FV loop at 36 weeks following intervention showed improvement of both the inspiratory and expiratory limbs
Fig. 2 Chest radiograph pre- and post-intervention. a Chest radiograph showed total left lung collapse. b Chest radiograph at 36 weeks following
intervention illustrating re-expansion of the left lung field
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Respiratory examination revealed tracheal deviation to
the left, decreased chest expansion, reduced vocal fremi-
tus and dullness to percussion of the left lung. Oxygen
saturation on room air was 95 %.
On this presentation, sputum smear examination for
AFB was negative. Flow volume (FV) loop was consist-
ent with fixed airway obstruction (Fig. 1a) with her best
functional vital capacity (FVC) of 2.03 litres (58 % pre-
dicted). Chest radiograph (Fig. 2a) and computed tomog-
raphy (CT) scan of thorax (Fig. 3a) showed total left
lung collapse. The CT thorax also revealed 1-cm seg-
ment of tracheal stenosis (Fig. 4a) and left main bron-
chus (LMB) stenosis (Fig. 5a) with mediastinal shift to
the left (Fig. 6a).
Flexible bronchoscopy revealed a web-like 90 % tra-
cheal stenosis and the visualisation of airways distally
from this point was not possible. A clinical judgement of
PTB reactivation was made based on the bronchoscopic
appearance and the presence of constitutional symptoms.
The standard four anti-TB regimen was therefore com-
menced. Patient was then referred to an interventional
pulmonology centre for bronchoscopic intervention.
The first intervention performed was sequential tracheal
dilatation to 10 mm via controlled radial expansion CRE®
balloon (Boston Scientifics, USA) and mechanical dilata-
tion with rigid bronchoscopy followed by mitomycin-C
application (0.4 mg/ml) with a total contact time of 8 min.
The first intervention was successful, as bronchoscopic
surveillance performed at 3, 8 and 16 weeks (Fig. 7a)
showed no recurrence of tracheal stenosis with a tracheal
diameter of 10 mm. The airway distal to the tracheal sten-
osis became accessible which subsequently revealed the
LMB stenosis with a pinpoint opening as previously re-
ported in the CT thorax. We then proceeded with dilata-
tion of the LMB.
The second intervention was performed at 20 weeks
and the stenosed LMB was dilated using a CRE® balloon
at 8, 9 and 10 mm. At 26 weeks, the balloon dilatation
Fig. 3 CT Thorax pre- and post-intervention. a Coronal view CT Thorax showed total left lung collapse. b Coronal view CT Thorax at 36 weeks
following intervention showing re-expansion of the left lung
a b
Fig. 4 CT Thorax pre- and post-intervention. a Lateral view of a CT Thorax showing 1 cm of total stenosis at the upper one third of trachea.
b Lateral view CT Thorax at 36 weeks following successful intervention
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was repeated with the adjuvant treatment of topical
mitomycin-C application (0.4 mg/mls) with the same
contact time of 8 min. These procedures were repeated
again at 36 weeks to re-examine further the LMB sten-
osis. There were no immediate complications.
Following these interventions, the patient showed sig-
nificant and sustained improvement. The FV loop
(Fig. 1b) illustrated improvement in both inspiratory and
expiratory limbs and the FVC increased to 2.91 litres
(83 % predicted). Chest radiograph (Fig. 2b) and CT
thorax showed re-expansion of the left lung (Fig. 3b),
tracheal patency (Fig. 4b) and the mediastinum back to
its original position (Fig. 6b).
The patient is currently able to climb more than four
flights of stairs and walk more than 1 kilometre without
dyspnoea. She had completed a total 9 months of anti-
TB therapy. She no longer requires oxygen and is back
to her usual daily activities.
Discussion
We report a rare case of multiple level tracheobronchial
stenoses secondary to endobronchial tuberculosis. The
risk factors present include female gender, symptom
duration of more than 4 weeks and multiple previous
episodes of PTB; these are significant predictors of
EBTB [4]. Our patient had a unique presentation in
which bronchoscopy revealed tracheal fibrostenosis as
well as LMB involvement. These are both rare sites for
EBTB as current literature reports that the right upper
lobe and right main bronchus are the most common
sites [5, 6, 12].
Although presentation of EBTB varies, patients are more
commonly reported to present with cough and wheezing
[13]. Localised rhonchi on respiratory examination should
prompt the clinician to assess for the presence of an endo-
bronchial lesion in which correlation of loop spirometry,
CT findings and bronchoscopy may aid the diagnosis. The
Fig. 5 Axial view of a CT Thorax at the main carina level pre- and post-intervention. a CT Thorax showed left main bronchus stenosis with
collapsed left lung. b CT Thorax at 36 weeks following intervention with residual left main bronchus stenosis and re-expansion of the
left lung
Fig. 6 Axial view CT Thorax pre- and post-intervention. a CT Thorax showed mediastinal shift to the left. b CT Thorax at 36 weeks following
intervention showed normal location of the mediastinum
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involvement of the trachea was the reason for the patient’s
rare presentation of dyspnea and stridor.
Simple tracheal stenosis can be treated endoscopic-
ally while complex stenosis should be evaluated for
surgery [8]. Various bronchoscopic techniques include
laser, cryosurgery, controlled heat application, balloon
dilatation and stent insertion are available [9–11]. Per-
sistent airway stenosis following balloon dilatation has
been described especially if active inflammation, calci-
fication and malacia are evident. Patients who require
more than one session of balloon dilatation may need
more definitive treatment such as stenting or ablative
procedures [10].
As there was no bronchomalacia evident in our pa-
tient, an airway stent was not inserted into the LMB to
avoid long-term complications associated with this for-
eign device. This option would be considered however,
if the LMB stenosis re-occurred following topical
mitomycin-C application.
The use of mitomycin-C as an adjunct therapy to
bronchoscopic procedures in our case was influenced by
reports of successful treatment in patients with tracheal
stenosis secondary to intubation [14, 15]. There are no
controlled studies and very few case reports in the litera-
ture describing the utility of mitomycin-C for trachea-
bronchial stenosis secondary to EBTB. Two previous re-
ports had shown the success of topical mitomycin-C for
obstructive granuloma and a 90 % occlusion of the
upper trachea secondary to EBTB [16, 17]. Mitomycin-C
is an antineoplastic antibiotic agent that inhibits fibro-
blast proliferation and modulates wound healing and
scarring. Due to its teratogenic effects, use in a women
of childbearing age woman should be coupled with
contraceptive use.
This patient was successfully managed with clinical
(symptoms and FV loop) and radiological improvements
at short-term follow-up, despite having residual LMB
stenosis. As there was no bronchomalacia, an airway
stent was not inserted to the LMB.
Conclusion
This case report contributes to the current literature and
evidence base that balloon dilatation and topical
mitomycin-C application should be considered in se-
lected patients with tracheobronchial stenosis post
EBTB. Importantly, this technique might obviate the
need for airway stenting and further invasive surgical
intervention.
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Fig. 7 Bronchoscopic findings (a) during presentation showing stenotic upper tracheal segment. b 3 weeks c 8 weeks and d
16 weeks post-intervention
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